期刊文献+

NT4p53(C22)Ant重组腺伴病毒对人Miapaca-Ⅱ胰腺癌细胞的杀伤作用

Killing effects of recombinant AAV expressing fusion peptide NT4p53 (C22) Ant on human pancreatic cancer(Miapaca)-Ⅱcells
下载PDF
导出
摘要 目的:研究NT4p53(C22)Ant重组腺伴病毒对人M iapaca-Ⅱ胰腺癌细胞杀伤作用.方法:构建NT4p53(C22)Ant,将其亚克隆于腺伴病毒载体中,经293细胞包装、扩增构成具有感染性的重组腺伴病毒AAV-NT4p53(C22)Ant,转染人胰腺癌M iapaca-Ⅱ细胞,经光镜下观察、MTT比色试验、PI染色实验及乳酸脱氢酶释放检测(LDH),观察AAV-NT4p53(C22)Ant对细胞的杀伤作用.结果:光镜下可见随AAV-NT4p53(C22)Ant感染Miapaca-Ⅱ细胞时间延长,肿瘤细胞数目明显减少;MTT实验检测发现细胞存活率明显降低(P<0.05);流式细胞检测凋亡细胞数目较对照组及空病毒组增加(P<0.05);LDH检测培养基中LDH只有轻度增加(P>0.05).结论:重组腺伴病毒NT4p53(C22)Ant对胰腺癌细胞有杀伤作用,并且是通过引起细胞凋亡而实现的. AIM: To study the killing effects of recombinant adeno-associated virus (AAV) expressing fusion peptide NT4p53 (C22) Ant on human pancreatic cancer Miapaca-Ⅱ cells. METHODS: NT4p53 (C22)Ant was constructed and subcloned into the vector of recombinant AAV, and that was amplified in 293 packaging cells. The recombinant plasmid AAV-NT4p53 (C22) Ant was transferred into Miapaca-Ⅱ cells. The direct effects on human pancreatic cancer cell line Miapaca- Ⅱ were detected with light microscope, MTT, flow cytometry and lactate dehydrogenase( LDH ) release assay. RESULTS: It could be observed under microscope that the AAV-NT4p53 (C22)Ant could directly kill the Miapaca- Ⅱ cells. MTT revealed that the survival rate of the cells was decreased obviously. Flow cytometry showed that the number of apoptotic cells was significantly increased in AAV- NT4p53 ( C22 ) Ant group as compared with control group and simple AAV group ( P 〈 0.05 ). LDH level went up a little ( P 〉 0. 05 ). CONCLUSION: The AAV-NT4p53 ( C22 ) Ant could cause the apoptosis of human pancreatic cancer Miapaca- Ⅱ cells to kill the cells directly.
作者 周琦 纪宗正
出处 《第四军医大学学报》 CAS 北大核心 2006年第22期2054-2056,共3页 Journal of the Fourth Military Medical University
关键词 NT4p53(C22)Ant 重组腺伴病毒 胰腺肿瘤 细胞系 NT4p53 (C22)Ant recombinant adeno-associated virus (rAAV) pancreatic neoplasms cell line
  • 相关文献

参考文献12

  • 1Bykov VJ,Issaeva N,Shilov A,et al.Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound[J].Nat Med,2002,8(3):282-288.
  • 2Winter M,Milne D,Dias S,et al.Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover[J].Biochemistry,2004,43(51):16356-16364.
  • 3Saleh J,Kreissler-Haag D,Montenarh M.p53 autoantibodies from patients with colorectal cancer recognize common epitopes in the N-or C-terminus of p53[J].Int J Oncol,2004,25(4):1149-1155.
  • 4Rosal R,Brandt-Rauf P,Pincus MR,et al.The role of alpha-helical structure in p53 peptides as a determinant for their mechanism of cell death:necrosis versus apoptosis[J].Adv Drug Deliv Rev,2005,57(4):653-660.
  • 5Li Y,Rosal RV,Brandt-Rauf PW,et al.Correlation between hydrophobic properties and efficiency of carrier-mediated membrane transduction and apoptosis of a p53 C-terminal peptide[J].Biochem Biophys Res Commun,2002,298(3):439-449.
  • 6Falke D,Fisher MH,Juliano RL.Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras[J].Biochim Biophys Acta,2004,1681(1):15-27.
  • 7Teruya K,Murphy AC,Burlin T,et al.Fmoc-based chemical synthesis and selective binding to supercoiled DNA of the p53 C-terminal segment and its phosphorylated and acetylated derivatives[J].J Pept Sci,2004,10(8):479-493.
  • 8Schwarze SR,Ho A,Vocero-Akbani A,et al.Invivo protein transduction:delivery of a biologically active protein into the mouse[J].Science,1999,285(3):1569-1572.
  • 9Lindgren ME,Hallbrink MM,Elmquist AM,et al.Passage of cell-penetrating peptides across a human epithelial cell layer in vitro[J].Biochem J,2004,377(1):69-76.
  • 10Gratton JP,Yu J,Griffith JW,et al.Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo[J].Nat Med,2003,9(3):357-362.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部